NasdaqGS:IONSBiotechs
Assessing Ionis Pharmaceuticals (IONS) Valuation As Shares Cool After A Multi Year Run
Recent stock performance and context
Ionis Pharmaceuticals (IONS) has seen its stock give back some ground recently, with the price down about 2% over the past week and roughly 1% over the past month, against a 7% decline over the past 3 months.
See our latest analysis for Ionis Pharmaceuticals.
Zooming out, Ionis Pharmaceuticals’ share price has cooled recently. However, its 1-year total shareholder return of 121.19% and 3-year total shareholder return of 89.41% indicate that longer term...